Biotech company Gelteq prices IPO at 4 per share
| GELS Stock | 1.86 0.05 2.76% |
Slightly above 50% of Gelteq Limited's private investors are presently thinking to get in. The analysis of overall sentiment of trading Gelteq Limited Ordinary stock suggests that some investors are interested at this time. Gelteq Limited's investing sentiment can be driven by a variety of factors including economic data, Gelteq Limited's earnings reports, geopolitical events, and overall market trends.
Gelteq |
Gelteq priced its IPO at 4 per share, expected to raise 5.2 million for manufacturing, marketing, and RD activities, listing on Nasdaq.
Read at seekingalpha.com
 |
Gelteq Limited Fundamental Analysis
We analyze Gelteq Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Gelteq Limited using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Gelteq Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Gelteq Limited is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Gelteq Limited Ordinary Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Gelteq Limited stock to make a market-neutral strategy. Peer analysis of Gelteq Limited could also be used in its relative valuation, which is a method of valuing Gelteq Limited by comparing valuation metrics with similar companies.
Peers
Gelteq Limited Related Equities
| SPNS | Sapiens International | 0.33 |
| ||
| NVNO | EnVVeno Medical | 0.62 |
| ||
| XPOF | Xponential Fitness | 1.17 |
| ||
| SSY | SunLink Health | 1.32 |
| ||
| CDNS | Cadence Design | 1.75 |
| ||
| NOW | ServiceNow | 2.68 |
|
Additional Tools for Gelteq Stock Analysis
When running Gelteq Limited's price analysis, check to measure Gelteq Limited's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gelteq Limited is operating at the current time. Most of Gelteq Limited's value examination focuses on studying past and present price action to predict the probability of Gelteq Limited's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gelteq Limited's price. Additionally, you may evaluate how the addition of Gelteq Limited to your portfolios can decrease your overall portfolio volatility.